CCL2 and acute kidney injury: Some studies in animals have shown that dexmedetomidine could prevent sepsis-induced AKI by reducing the levels of inflammatory cytokines, such as tumor necrosis factor-alpha, monocyte chemotactic protein-1 and interleukin-6, and ameliorate renal dysfunction [29, 30].